Glaxo asthma drug clears key hurdle in Europe – MarketWatch


Yahoo News

Glaxo asthma drug clears key hurdle in Europe
MarketWatch
LONDON–GlaxoSmithKline PLC's [GSK.LN] new severe-asthma medicine has received a positive opinion from the scientific committee of the European Medicines Agency for use in adults, clearing a key hurdle towards gaining marketing approval in Europe.
EU regulator backs approval for GSK injectable asthma drugYahoo News
GlaxoSmithKline plc (ADR) To Lead Asthma MarketBidness ETC
GlaxoSmithKline's asthma injection heads for EU approvalFierceBiotech

all 24 news articles »

View full post on asthma – Google News

FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD – HIT Consultant


HIT Consultant

FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD
HIT Consultant
The Propeller Health system has been used by patients with asthma or COPD in over 35 commercial programs across the US, including major healthcare systems, payers, employers and other commercial partners. These clearances mark the third and fourth …
FDA grants 501(k) clearance for platform used in association to treat asthma, COPDHealio

all 18 news articles »

View full post on asthma – Google News

FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD – HIT Consultant – HIT Consultant


HIT Consultant

FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD – HIT Consultant
HIT Consultant
The Propeller Health system has been used by patients with asthma or COPD in over 35 commercial programs across the US, including major healthcare systems, payers, employers and other commercial partners. These clearances mark the third and fourth …
FDA Clears 2 New Propeller Health Devices That Track Respiratory Meds | XconomyXconomy
Propeller Health gets FDA nod to sell app, sensor with GSK inhalers FierceMedicalDevices (press release) (registration)
Propeller Health Receives FDA Clearance for the Propeller Platform in Satellite PR News (press release)

all 7 news articles »

View full post on asthma – Google News

FDA clears Teva asthma med (TEVA) – Seeking Alpha (registration)


Nasdaq

FDA clears Teva asthma med (TEVA)
Seeking Alpha (registration)
The FDA approves Teva Pharmaceutical Industries' (NYSE:TEVA) ProAir RespiClick (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients at least 12 years old with reversible obstructive airway disease and for
Teva Announces FDA Approval of ProAir® RespiClickBusiness Wire (press release)
Teva Announces FDA Approval of ProAir(R) RespiClickFinances.com

all 5 news articles »

View full post on asthma – Google News

FDA Clears Palatin Technologies’ IND Filing to Commence Clinical Studies for … – AUTO-MOBI.info (press release)

FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for
AUTO-MOBI.info (press release)
"We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to

and more »

View full post on asthma – Google News

FDA Clears Palatin Technologies’ IND Filing to Commence Clinical Studies for … – DigitalJournal.com (press release)

FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for
DigitalJournal.com (press release)
"We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to

and more »

View full post on asthma – Google News

FDA Clears Palatin Technologies’ IND Filing to Commence Clinical Studies for … – PR Newswire (press release)

FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for
PR Newswire (press release)
"We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to

and more »

View full post on asthma – Google News

CAS clears Australian swimmer Ryan Napoleon to participate in Delhi CWG – Sify


CBC.ca

CAS clears Australian swimmer Ryan Napoleon to participate in Delhi CWG
Sify
He failed a drug test after using an asthma medication that was mislabelled by his pharmacist. Although the FINA anti-doping panel accepted that he did not
CAS clears Napoleon to swim in Commonwealth GamesUSA Today
Napoleon eligible for Games after doping ban back-datedReuters Africa
Relieved Napoleon racing against timeABC Online
AFP –Sydney Morning Herald
all 81 news articles »

View full post on asthma – Google News